Vivek Gupta takes charge as World Wide VP for Acceliant

30 Aug, 2016

Santa Clara, California, Bangalore, India, Aug 30, 2016 - Acceliant, the medical industry technology division of Trianz, announces the appointment of Vivek Gupta as a World Wide VP, who will be heading the sales for Acceliant suite of products. Vivek Gupta also serves as the World Wide VP in the parent company, Trianz. Vivek is an accomplished technology leader with demonstrated track record of driving sales organisations. Previously, Vivek was part of the leadership team at Amazon Web Services (AWS) for India & South Asia where he helped several global organizations to embrace Cloud technologies. In this role Vivek will oversee sales and client relations as well as overall product roadmap for Acceliant globally. Santhosh S. Nagaraj, the current sales head at Acceliant will continue to focus full time on leadership role in client relationships with the parent entity, Trianz.

Commenting on the change, Sri Manchala, Chairman & CEO, said, "Vivek comes with an enormous sales and client partnership experience, Acceliant will be aptly benefit under his leadership and he will continue to keep the momentum and help us tap new partnerships and opportunities in the emerging Clinical trial markets globally".

Acceliant appreciates and recognizes the services rendered by Santhosh S. Nagaraj for his stellar role in laying the right strategy for Acceliant's growth and expanding it's client base in India and the US.

Speaking on this new responsibility, Vivek Gupta, World Wide VP - Sales, said, "I am glad to take up this new responsibility at a time when there are new set of emerging opportunities and challenges for clinical data management with respect to regulatory changes as well as technology upgrades. Acceliant has the potential to make significant strides in addressing these. I look forward to this opportunity."

About Acceliant

Acceliant is the medical industry technology division of Trianz, a global technology services and solutions company. A pioneer in the EDC industry, Acceliant has been providing solutions in the clinical trial management space since 1999. The company caters to the needs of the pharmaceutical, biotechnology, medical device, CRO, and non-profit drug research industries. Acceliant solutions have helped facilitate clinical data management in hundreds of trials worldwide in dozens of therapeutic areas for global giants as well as emerging healthcare innovators. For more information, please visit our website at www.acceliant.com.

Prashant Bhavaraju